Interleukin-2 therapeutic(Campbell Neurosciences)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterleukin-2 therapeutic(Campbell Neurosciences)
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionImmunostimulantsInterleukin-2 receptor agonistsInterleukin-2 replacements +[4] 
TargetsInterleukin-2 receptorInterleukin-2
Therapy Area/IndicationsDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsDepression
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A